These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 12187754)
1. [Peptic ulcer in patients with diabetes mellitus]. Sato T; Kitahara F; Nakamura T; Kojima Y; Fujino MA Nihon Rinsho; 2002 Aug; 60(8):1580-4. PubMed ID: 12187754 [TBL] [Abstract][Full Text] [Related]
2. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Labenz J; Börsch G Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Schimke K; Chubb SA; Davis WA; Phillips P; Davis TM Diabet Med; 2009 Jan; 26(1):70-5. PubMed ID: 19125763 [TBL] [Abstract][Full Text] [Related]
7. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial]. Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745 [TBL] [Abstract][Full Text] [Related]
8. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886 [TBL] [Abstract][Full Text] [Related]
11. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780 [TBL] [Abstract][Full Text] [Related]
12. [The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy]. Köksal H Mikrobiyol Bul; 1993 Jul; 27(3):266-70. PubMed ID: 8361417 [TBL] [Abstract][Full Text] [Related]
13. [Peptic ulcer and Helicobacter pylori, diagnosis and therapy]. Fixa B; Komárková O Cas Lek Cesk; 1999 Jun; 138(12):355-8. PubMed ID: 10566201 [TBL] [Abstract][Full Text] [Related]
14. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043 [TBL] [Abstract][Full Text] [Related]
17. [A multicenter study of Chinese patent medicine wenweishu/yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer]. ; Hu FL Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):75-8. PubMed ID: 20356485 [TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy. O'Connor HJ; McGee C; Ghabash NM; Cunnane K Hepatogastroenterology; 2001; 48(40):1064-8. PubMed ID: 11490801 [TBL] [Abstract][Full Text] [Related]
20. [Peptic ulcer recurrence after successful eradication of Helicobacter pylori--clinical characteristics and management]. Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T Nihon Rinsho; 2004 Mar; 62(3):495-8. PubMed ID: 15038093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]